Dapagliflozin: A Review in Type 2 Diabetes

Dapagliflozin ( Forxiga®) is a highly potent, reversible and selective sodium-glucose cotransporter-2 inhibitor indicated worldwide for the treatment of type 2 diabetes (T2D). In the EU, oral dapagliflozin once daily is approved for use as monotherapy (in patients who are intolerant of metformin) and as add-on combination therapy (with other glucose-lowering agents, including insulin) for …

Long-Term Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus…

Dapagliflozin, a selective inhibitor of sodium–glucose cotransporter 2, may improve glycemic control with a lower dose of insulin and attenuate the associated weight gain in patients with inadequate control despite high doses of insulin.

Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Di…

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

-

Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diab…

Combining metformin (XR) with dapagliflozin to initiate pharmacotherapy in patients with type 2 diabetes (T2D) and high baseline HbA1c may be advantageous. We conducted two randomised, double-blind, three-arm 24-week trials in treatment-naı¨ve patients to compare dapagliflozin plus metformin, dapagliflozin alone and metformin alone.

Clindamycin treatment of Staphylococcus aureus expressing inducible clindamyc…

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

-

Acceptability of Single-dose Clindamycin Gel for Bacterial Vaginosis: A Rando…

The goal of this study was to assess the acceptability of a single-dose bioadhesive 2% clindamycin vaginal gel for bacterial vaginosis (BV).

Effectiveness of adjunctive clindamycin in β-lactam antibiotictreated patien…

Clindamycin is strongly recommended as an adjunctive treatment to β-lactam antibiotics in patients with severe invasive group A β-haemolytic streptococcal (iGAS) infections. However, there is little evidence of a benefit in the use of clindamycin in humans, and its role, if any, in treating patients with invasive non-group A/B β-haemolytic streptococcal (iNABS) infections is unclear.

Methylprednisolone or dexamethasone, which one is superior corticosteroid in …

Although almost a year has passed since the Coronavirus disease 2019 (COVID-19) outbreak and promising reports of vaccines have been presented, we still have a long way until these measures are available for all. Furthermore, the most appropriate corticosteroid and dose in the treatment of COVID-19 have remained uncertain. We conducted a study to assess the effectiveness of methylprednisolone t…

Low Dose, Short-Term Oral Methylprednisolone for Nasal Polyps: A Randomized D…

To determine the efficacy of a 7-day treatment of methylprednisolone 16mg in reducing the size of nasal polyps and on improvement of nasal symptoms.

Oral Methylprednisolone Acetate (Medrol Tablets) for Seasonal Rhinitis: Exami…

The authors compared the effect of several doses an oral corticosteroid on symptom profile and severity in ragweed hay fever. Thirty-one patients were randomized to receive 06, 12, or 24 mg methylprednisolone (Medrol Tablets [MP], Upjohn, Kalamazoo, MI). A baseline week in which no treatment was given preceded the treatment comparison. At the end of this week, symptom diaries showed that most o…